ProfileGDS4132 / 220322_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 39% 32% 41% 37% 32% 31% 31% 44% 44% 35% 30% 32% 36% 32% 29% 21% 28% 46% 37% 32% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101100.69939
GSM201543Muscle PCOS pioglitazone 12172.026132
GSM201544Muscle PCOS pioglitazone 161109.92241
GSM201545Muscle PCOS pioglitazone 201101.72637
GSM201829Muscle PCOS pioglitazone 23183.695932
GSM201830Muscle PCOS pioglitazon 25179.712831
GSM201831Muscle PCOS pioglitazone 27175.79331
GSM201832Muscle PCOS pioglitazone 31114.48544
GSM201833Muscle PCOS pioglitazone 41108.15644
GSM201834Muscle PCOS pioglitazone 8184.969835
GSM201835Muscle PCOS after pioglitazone 10260.087130
GSM201836Muscle PCOS after pioglitazone 12267.790132
GSM201837Muscle PCOS after pioglitazone 16277.315436
GSM201838Muscle PCOS after pioglitazone 20270.616732
GSM201839Muscle PCOS after pioglitazone 23263.557329
GSM201840Muscle PCOS after pioglitazone 25244.860421
GSM201841Muscle PCOS after pioglitazone 27255.042828
GSM201842Muscle PCOS after pioglitazone 32101.14146
GSM201843Muscle PCOS after pioglitazone 4291.656537
GSM201844Muscle PCOS after pioglitazone 8272.936632